p53 and regulation of DNA damage recognition during nucleotide excision repair, DNA Repair, vol.2, issue.9, pp.947-954, 2003. ,
DOI : 10.1016/S1568-7864(03)00087-9
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial, The Lancet Oncology, vol.11, issue.1, pp.55-65, 2010. ,
DOI : 10.1016/S1470-2045(09)70314-6
Progesterone receptors - animal models and cell signaling in breast cancer: The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis, Breast Cancer Research, vol.72, issue.5, pp.197-201, 2002. ,
DOI : 10.1023/A:1014820500738
Relationship between expression of 5-fluorouracil metabolic enzymes and 5-fluorouracil sensitivity in esophageal carcinoma cell lines, Diseases of the Esophagus, vol.21, issue.1, pp.15-20, 2008. ,
DOI : 10.1111/j.1442-2050.2007.00700.x
Gene Expression Profiles Predict Complete Pathologic Response to Neoadjuvant Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy in Breast Cancer, Journal of Clinical Oncology, vol.22, issue.12, pp.2284-2293, 2004. ,
DOI : 10.1200/JCO.2004.05.166
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-??B, Journal of Clinical Investigation, vol.107, issue.3, pp.241-246, 2001. ,
DOI : 10.1172/JCI11991
Increased levels of tyrosinated ??-, ??III-, and ??IV-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells, Biochemical and Biophysical Research Communications, vol.293, issue.1, pp.598-601, 2002. ,
DOI : 10.1016/S0006-291X(02)00269-3
Overexpression of DDB2 enhances the sensitivity of human ovarian cancer cells to cisplatin by augmenting cellular apoptosis, International Journal of Cancer, vol.4, 2009. ,
DOI : 10.1128/MCB.18.1.240
Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair, Oncogene, vol.12, issue.15, 1964. ,
DOI : 10.1016/S0006-2952(99)00372-X
Metabolic activation of adriamycin by NADPH-cytochrome P450 reductase; overview of its biological and biochemical effects, Acta Biochim. Pol, vol.49, pp.323-331, 2002. ,
ROS, stress-activated kinases and stress signaling in cancer, EMBO reports, vol.3, issue.5, pp.420-425, 2002. ,
DOI : 10.1093/embo-reports/kvf094
Identification of signal transduction pathways involved in constitutive NF-??B activation in breast cancer cells, Oncogene, vol.21, issue.13, pp.2066-2078, 2002. ,
DOI : 10.1038/sj.onc.1205243
Nouveaux facteurs prédictifs de chimiosensibilité dans le cancer du sein, Bulletin Du Cancer, vol.95, pp.943-950, 2008. ,
Methylated DNA Immunoprecipitation (MeDIP) from Low Amounts of Cells, pp.149-158, 2012. ,
DOI : 10.1007/978-1-62703-011-3_9
The role of apoptosis in cancer development and treatment response, Nat Rev Cancer, vol.5, pp.231-237, 2005. ,
The Nuclear Transcription Factor ??B/bcl-2 Pathway Correlates with Pathologic Complete Response to Doxorubicin-Based Neoadjuvant Chemotherapy in Human Breast Cancer, Clinical Cancer Research, vol.11, issue.23, pp.8398-8402, 2005. ,
DOI : 10.1158/1078-0432.CCR-05-0885
Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer, JNCI Journal of the National Cancer Institute, vol.98, issue.17, pp.1183-1192, 2006. ,
DOI : 10.1093/jnci/djj329
Update on endocrine therapy for breast cancer, Clin Cancer Res, vol.4, pp.527-534, 1998. ,
-Methylation of Damaged DNA-binding Protein 2 (DDB2) and Its Function in Nucleotide Excision Repair, Journal of Biological Chemistry, vol.18, issue.23, 2014. ,
DOI : 10.1126/science.1063127
URL : https://hal.archives-ouvertes.fr/jpa-00250938
Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death?, Journal of Cell Science, vol.115, issue.24, pp.4727-4734, 2002. ,
DOI : 10.1242/jcs.00210
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study, JAMA, vol.295, issue.21, pp.2492-2502, 2006. ,
DOI : 10.1001/jama.295.21.2492
Comparison and Identification of Estrogen-Receptor Related Gene Expression Profiles in Breast Cancer of Different Ethnic Origins, Breast Cancer (Auckl), vol.1, pp.35-49, 2008. ,
Transcriptional regulation of human DNA repair genes following genotoxic stress: trigger mechanisms, inducible responses and genotoxic adaptation, Nucleic Acids Research, vol.41, issue.18, 2013. ,
DOI : 10.1093/nar/gkt635
Induction of Apoptosis in Estrogen Receptor-Negative Breast Cancer Cells by Natural and Synthetic Cyclopentenones: Role of the I??B Kinase/Nuclear Factor-??B Pathway, Molecular Pharmacology, vol.70, issue.5, pp.1812-1821, 2006. ,
DOI : 10.1124/mol.106.025759
Reactive Oxygen Species as Mediators of Cellular Senescence, IUBMB Life (International Union of Biochemistry and Molecular Biology: Life), vol.57, issue.4-5, pp.277-281, 2005. ,
DOI : 10.1080/15216540500091890
Marqueurs pronostiques et prédictifs de réponse aux traitements des cancers du sein, Bulletin Du Cancer, vol.97, pp.1297-1304, 2010. ,
The Power and Potential of Doxorubicin-DNA Adducts, IUBMB Life (International Union of Biochemistry and Molecular Biology: Life), vol.57, issue.2, pp.73-81, 2005. ,
DOI : 10.1080/15216540500079093
An Integrated Database of Chemosensitivity, p.55, 2002. ,
Breast cancer incidence and time trend in France from 1990 to 2007: a population-based study from two French cancer registries, Annals of Oncology, vol.22, issue.2, pp.329-334, 2011. ,
DOI : 10.1093/annonc/mdq396
Raf-1 and Bcl-2 induce distinct and common pathways that contribute to breast cancer drug resistance, Clin. Cancer Res, vol.9, pp.1161-1170, 2003. ,
Mutation analysis of the apoptotic ?death-receptors? and the adaptors TRADD and FADD/MORT-1 in osteosarcoma tumor samples and osteosarcoma cell lines, International Journal of Cancer, vol.59, issue.5, pp.661-667, 2004. ,
DOI : 10.4161/cbt.2.3.398
Manganese superoxide dismutase regulation and cancer, Free Radical Biology and Medicine, vol.52, issue.11-12, pp.2209-2222, 2012. ,
DOI : 10.1016/j.freeradbiomed.2012.03.009
Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells, Cell Growth Differ, vol.12, pp.129-135, 2001. ,
Predictive Markers in Breast and Other Cancers: A Review, Clinical Chemistry, vol.51, issue.3, pp.494-503, 2005. ,
DOI : 10.1373/clinchem.2004.046227
Mammalian Caspases: Structure, Activation, Substrates, and Functions During Apoptosis, Annual Review of Biochemistry, vol.68, issue.1, pp.383-424, 1999. ,
DOI : 10.1146/annurev.biochem.68.1.383
A new method for accurate assessment of DNA quality after bisulfite treatment, Nucleic Acids Research, vol.35, issue.5, p.29, 2007. ,
DOI : 10.1093/nar/gkl1134
Targeted therapy against Bcl-2-related proteins in breast cancer cells, Breast Cancer Research, vol.711, issue.6, p.940, 2005. ,
DOI : 10.1200/jco.2004.22.14_suppl.7505
DDB2: A Novel Regulator of NF-??B and Breast Tumor Invasion, Cancer Research, vol.73, issue.16, 2013. ,
DOI : 10.1158/0008-5472.CAN-12-3655
Evaluation of Activity and Combination Strategies with the Microtubule-Targeting Drug Sagopilone in Breast Cancer Cell Lines, Frontiers in Oncology, vol.1, p.44, 2011. ,
DOI : 10.3389/fonc.2011.00044
The Mitochondrial Pathways of Apoptosis, Advances in Mitochondrial Medicine, pp.157-183, 2012. ,
DOI : 10.1007/978-94-007-2869-1_7
VEGF-Mediated Angiogenesis Links EMT-Induced Cancer Stemness to Tumor Initiation, Cancer Research, vol.74, issue.5, pp.1566-1575, 2014. ,
DOI : 10.1158/0008-5472.CAN-13-1641
Demethylation of the Estrogen Receptor Gene in Estrogen Receptor-negative Breast Cancer Cells Can Reactivate Estrogen Receptor Gene Expression, Cancer Res, vol.55, pp.2279-2283, 1995. ,
Many cuts to ruin: a comprehensive update of caspase substrates, Cell Death and Differentiation, vol.10, issue.1, pp.76-100, 2003. ,
DOI : 10.1038/sj.cdd.4401160
Tumor resistance to apoptosis, International Journal of Cancer, vol.7, issue.3, pp.511-515, 2009. ,
DOI : 10.1161/01.RES.88.3.282
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy, Oncogene, vol.6, issue.34, pp.4798-4811, 2006. ,
DOI : 10.1016/S0092-8674(00)80501-2
Integrative analysis of gene expression patterns predicts specific modulations of defined cell functions by estrogen and tamoxifen in MCF7 breast cancer cells, Journal of Molecular Endocrinology, vol.34, issue.1, pp.61-75, 2005. ,
DOI : 10.1677/jme.1.01631
URL : https://hal.archives-ouvertes.fr/hal-00126095
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes, Cell Death and Differentiation, vol.15, issue.8, pp.1093-1107, 2009. ,
DOI : 10.4161/auto.5338
URL : https://hal.archives-ouvertes.fr/inserm-00420382
A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin, Biochemical Pharmacology, vol.57, issue.7, pp.727-741, 1999. ,
DOI : 10.1016/S0006-2952(98)00307-4
The Four Faces of Autophagy: Implications for Cancer Therapy, Cancer Research, vol.74, issue.3, 2014. ,
DOI : 10.1158/0008-5472.CAN-13-2966
Apoptosis and cancer: mutations within caspase genes, Journal of Medical Genetics, vol.46, issue.8, pp.497-510, 2009. ,
DOI : 10.1136/jmg.2009.066944
URL : http://liu.diva-portal.org/smash/get/diva2:566576/FULLTEXT01
Epigenetic Information and Estrogen Receptor Alpha Expression in Breast Cancer, The Oncologist, vol.11, issue.1, pp.1-8, 2006. ,
DOI : 10.1634/theoncologist.11-1-1
Redox Regulation of Mitochondrial Function, Antioxidants & Redox Signaling, vol.16, issue.11, pp.1323-1367, 2012. ,
DOI : 10.1089/ars.2011.4123
DDB, a Putative DNA Repair Protein, Can Function as a Transcriptional Partner of E2F1, Molecular and Cellular Biology, vol.18, issue.1, pp.240-249, 1998. ,
DOI : 10.1128/MCB.18.1.240
A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker, Cancer Chemotherapy and Pharmacology, vol.23, issue.Suppl 6, pp.789-797, 2013. ,
DOI : 10.1200/JCO.2005.01.305
TNF-?? in Cancer Treatment: Molecular Insights, Antitumor Effects, and Clinical Utility, The Oncologist, vol.11, issue.4, pp.397-408, 2006. ,
DOI : 10.1634/theoncologist.11-4-397
Treatment of Breast Cancer, New England Journal of Medicine, vol.339, issue.14, pp.974-984, 1998. ,
DOI : 10.1056/NEJM199810013391407
Cell Death, New England Journal of Medicine, vol.361, issue.16, pp.1570-1583, 2009. ,
DOI : 10.1056/NEJMra0901217
The molecular portraits of breast tumors are conserved across microarray platforms, BMC Genomics, vol.7, issue.1, p.96, 2006. ,
DOI : 10.1186/1471-2164-7-96
Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D, Oncogene, vol.302, issue.55, pp.7305-7310, 2006. ,
DOI : 10.4161/cc.2.4.426
Human DDB2 splicing variants are dominant negative inhibitors of UV-damaged DNA repair, Biochemical and Biophysical Research Communications, vol.314, issue.4, pp.1036-1043, 2004. ,
DOI : 10.1016/j.bbrc.2004.01.003
Clinical implications of thymidylate synthetase, dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase activity levels in colorectal carcinoma following radical resection and administration of adjuvant 5-FU chemotherapy, BMC Cancer, vol.24, issue.1, p.188, 2008. ,
DOI : 10.1159/000098110
Abnormal regulation of DDB2 gene expression in xeroderma pigmentosum group E strains, Oncogene, vol.20, issue.48, pp.7041-7050, 2001. ,
DOI : 10.1038/sj.onc.1204909
Impaired Regulation of Tumor Suppressor p53 Caused by Mutations in the Xeroderma Pigmentosum DDB2 Gene: Mutual Regulatory Interactions between p48DDB2 and p53, Molecular and Cellular Biology, vol.23, issue.21, pp.7540-7553, 2003. ,
DOI : 10.1128/MCB.23.21.7540-7553.2003
Ddb2 is a haploinsufficient tumor suppressor and controls spontaneous germ cell apoptosis, Human Molecular Genetics, vol.16, issue.13, pp.1578-1586, 2007. ,
DOI : 10.1093/hmg/ddm107
Amplification and Deletion of Topoisomerase II? Associate with ErbB, 2000. ,
Doxorubicin and Paclitaxel Versus Fluorouracil, Doxorubicin, and Cyclophosphamide as First-Line Therapy for Women With Metastatic Breast Cancer: Final Results of a Randomized Phase III Multicenter Trial, Journal of Clinical Oncology, vol.19, issue.6, pp.1707-1715, 2001. ,
DOI : 10.1200/JCO.2001.19.6.1707
Modulating autophagy for therapeutic benefit, Autophagy, vol.3, pp.464-467, 2007. ,
The DDB1-CUL4ADDB2 ubiquitin ligase is deficient in xeroderma pigmentosum group E and targets histone H2A at UV-damaged DNA sites, Proceedings of the National Academy of Sciences, vol.117, issue.5, pp.2588-2593, 2006. ,
DOI : 10.1046/j.0022-202x.2001.01540.x
Damaged DNA Binding Protein 2 Plays a Role in Breast Cancer Cell Growth, PLoS ONE, vol.48, issue.4, 2002. ,
DOI : 10.1371/journal.pone.0002002.s003
URL : https://hal.archives-ouvertes.fr/hal-00276571
Role of manganese superoxide dismutase on growth and invasive properties of human estrogen-independent breast cancer cells, Breast Cancer Research and Treatment, vol.8, issue.2, pp.203-215, 2008. ,
DOI : 10.1128/MCB.17.7.3629
Induction of Apoptosis by Cancer Chemotherapy, Experimental Cell Research, vol.256, issue.1, pp.42-49, 2000. ,
DOI : 10.1006/excr.2000.4838
Expression of metabolismrelated proteins in triple-negative breast cancer, Int J Clin Exp Pathol, vol.7, pp.301-312, 2013. ,
Superoxide dismutases in malignant cells and human tumors, Free Radical Biology and Medicine, vol.36, issue.6, pp.718-744, 2004. ,
DOI : 10.1016/j.freeradbiomed.2003.12.010
Retrospective Analysis of Topoisomerase IIa Amplifications and Deletions As Predictive Markers in Primary Breast Cancer Patients Randomly Assigned to Cyclophosphamide, Methotrexate, and Fluorouracil or Cyclophosphamide, Epirubicin, and Fluorouracil: Danish Breast Cancer Cooperative Group, Journal of Clinical Oncology, vol.23, issue.30, 2005. ,
DOI : 10.1200/JCO.2005.11.007
The landscape of histone modifications across 1% of the human genome in five human cell lines, Genome Research, vol.17, issue.6, pp.691-707, 2007. ,
DOI : 10.1101/gr.5704207
Mitochondria in cancer, Oncogene, vol.117, issue.34, pp.4630-4632, 2006. ,
DOI : 10.1038/sj.onc.1201989
Mitochondrial Membrane Permeabilization in Cell Death, Physiological Reviews, vol.87, issue.1, pp.99-163, 2007. ,
DOI : 10.1152/physrev.00013.2006
URL : https://hal.archives-ouvertes.fr/hal-00172652
Manganese Superoxide Dismutase Is a Promising Target for Enhancing Chemosensitivity of Basal-Like Breast Carcinoma, Antioxidants & Redox Signaling, vol.20, issue.15, pp.2326-2346, 2014. ,
DOI : 10.1089/ars.2013.5295
Changes in mitochondrial redox state, membrane potential and calcium precede mitochondrial dysfunction in doxorubicin-induced cell death, BBA) - Molecular Cell Research 1813, pp.1144-1152, 2011. ,
DOI : 10.1016/j.bbamcr.2011.03.002
URL : https://hal.archives-ouvertes.fr/inserm-00633082
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4, Nature, vol.244, issue.5259, pp.680-685, 1970. ,
DOI : 10.1101/SQB.1963.028.01.053
Mitochondrial DNA Instability and Metabolic Shift in Human Cancers, International Journal of Molecular Sciences, vol.104, issue.2, pp.674-701, 2009. ,
DOI : 10.1073/pnas.0700690104
Xeroderma pigmentosum, Orphanet Journal of Rare Diseases, vol.6, issue.1, 2011. ,
DOI : 10.1073/pnas.022473899
URL : https://hal.archives-ouvertes.fr/inserm-00436508
The insulin-like growth factor system and cancer, Cancer Letters, vol.195, issue.2, pp.127-137, 2003. ,
DOI : 10.1016/S0304-3835(03)00159-9
Targeting transcription factor NF-??B to overcome chemoresistance and radioresistance in cancer therapy, BBA) -Reviews on Cancer 1805, pp.167-180, 2010. ,
DOI : 10.1016/j.bbcan.2010.01.002
53BP1 Sensitizes Breast Cancer Cells to 5-Fluorouracil, PLoS ONE, vol.86, issue.9, p.74928, 2013. ,
DOI : 10.1371/journal.pone.0074928.t002
Mutant p53 mediates survival of breast cancer cells, British Journal of Cancer, vol.60, issue.9, pp.1606-1612, 2009. ,
DOI : 10.1038/sj.onc.1206724
TAp63?? enhances nucleotide excision repair through transcriptional regulation of DNA repair genes, DNA Repair, vol.11, issue.2, pp.167-176, 2012. ,
DOI : 10.1016/j.dnarep.2011.10.016
Endonuclease G: a mitochondrial protein released in apoptosis and involved in caspase-independent DNA degradation, Cell Death and Differentiation, vol.8, issue.12, pp.1136-1142, 2001. ,
DOI : 10.1038/sj.cdd.4400944
Refined structure of ????-tubulin at 3.5 ?? resolution 1 1Edited by I. A. Wilson, Journal of Molecular Biology, vol.313, issue.5, pp.1045-1057, 2001. ,
DOI : 10.1006/jmbi.2001.5077
DDB2 promotes chromatin decondensation at UV-induced DNA damage, The Journal of Cell Biology, vol.60, issue.2, pp.267-281, 2012. ,
DOI : 10.1128/MCB.00695-06
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328393
Human STAGA Complex Is a Chromatin-Acetylating Transcription Coactivator That Interacts with Pre-mRNA Splicing and DNA Damage-Binding Factors In Vivo, Molecular and Cellular Biology, vol.21, issue.20, pp.6782-6795, 2001. ,
DOI : 10.1128/MCB.21.20.6782-6795.2001
ABC of breast diseases: Breast cancer---epidemiology, risk factors, and genetics, BMJ, vol.321, issue.7261, pp.624-628, 2000. ,
DOI : 10.1136/bmj.321.7261.624
Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin, Clin. Cancer Res, vol.4, pp.389-398, 1998. ,
A novel cis -acting element from the 3???UTR of DNA damage-binding protein 2 mRNA links transcriptional and post-transcriptional regulation of gene expression, Nucleic Acids Research, vol.41, issue.11, pp.5692-5703, 2013. ,
DOI : 10.1093/nar/gkt279
Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas, Blood, vol.109, issue.1, pp.271-280, 2007. ,
DOI : 10.1182/blood-2006-06-026500
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice, Science, vol.16, issue.7, pp.1573-1577, 2011. ,
DOI : 10.1038/cdd.2009.46
Gene Expression in Human Breast Cancer Cells, Journal of Biological Chemistry, vol.10, issue.21, pp.14165-14176, 2009. ,
DOI : 10.1002/(SICI)1098-2744(199911)26:3<180::AID-MC7>3.0.CO;2-4
Methylated DNA Immunoprecipitation (MeDIP), pp.55-64, 2009. ,
DOI : 10.1007/978-1-59745-522-0_5
Th??rapie cibl??e et cancer du sein??: ??tat de l???art, Pathologie Biologie, vol.60, issue.4, pp.254-263, 2012. ,
DOI : 10.1016/j.patbio.2012.05.012
The Xeroderma Pigmentosum Group E Gene Product DDB2 Is a Specific Target of Cullin 4A in Mammalian Cells, Molecular and Cellular Biology, vol.21, issue.20, pp.6738-6747, 2001. ,
DOI : 10.1128/MCB.21.20.6738-6747.2001
Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells, Breast Cancer Research, vol.23, issue.5 Suppl 16, p.12, 2009. ,
DOI : 10.1016/j.orthres.2005.01.018
Basal transcriptional regulation of human damage-specific DNA-binding protein genes DDB1 and DDB2 by Sp1, E2F, N-myc and NF1 elements, Nucleic Acids Research, vol.31, issue.2, pp.562-569, 2003. ,
DOI : 10.1093/nar/gkg152
Autophagy as a mediator of chemotherapy-induced cell death in cancer, Biochemical Pharmacology, vol.82, issue.5, pp.427-434, 2011. ,
DOI : 10.1016/j.bcp.2011.06.015
URL : https://hal.archives-ouvertes.fr/hal-00721647
Mechanism of the tumor suppressive effect of MnSOD overexpression, Biomedicine & Pharmacotherapy, vol.59, issue.4, pp.143-148, 2005. ,
DOI : 10.1016/j.biopha.2005.03.006
Multiple Skin Cancers in Adults with Mutations in the XP-E (DDB2) DNA Repair Gene, Journal of Investigative Dermatology, vol.131, issue.3, pp.785-788, 2011. ,
DOI : 10.1038/jid.2010.352
Mechanisms of Taxol resistance related to microtubules, Oncogene, vol.22, issue.47, pp.7280-7295, 2003. ,
DOI : 10.1038/sj.onc.1206934
Translocation of a UV-damaged DNA binding protein into a tight association with chromatin after treatment of mammalian cells with UV light, J Cell Sci, vol.110, pp.1159-1168, 1997. ,
Defining Characteristics of Types I and II Apoptotic Cells in Response to TRAIL, Neoplasia, vol.4, issue.6, pp.551-557, 2002. ,
DOI : 10.1038/sj.neo.7900270
Molecular portraits of human breast tumours, Nature, vol.406, issue.6797, pp.747-752, 2000. ,
DOI : 10.1038/35021093
Role of reactive oxygen species and cardiolipin in the release of cytochrome c from mitochondria, The FASEB Journal, vol.17, issue.15, pp.2202-2208, 2003. ,
DOI : 10.1096/fj.03-0012com
Molecular Mechanism of Global Genome Nucleotide Excision Repair, Acta Naturae, vol.6, pp.23-34, 2014. ,
A new mathematical model for relative quantification in real-time RT-PCR, Nucleic Acids Research, vol.29, issue.9, p.45, 2001. ,
DOI : 10.1093/nar/29.9.e45
Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate, Cancer Research, vol.68, issue.22, pp.9280-9290, 2008. ,
DOI : 10.1158/0008-5472.CAN-08-1776
Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion, Critical Reviews in Oncology/Hematology, vol.51, issue.1, pp.55-67, 2004. ,
DOI : 10.1016/j.critrevonc.2004.02.001
URL : https://hal.archives-ouvertes.fr/inserm-00144757
A comprehensive catalogue of somatic mutations from a human cancer genome, Nature, vol.19, issue.7278, pp.191-196, 2010. ,
DOI : 10.1016/j.mrfmmm.2004.11.013
A small-cell lung cancer genome with complex signatures of tobacco exposure, Nature, vol.34, issue.7278, pp.184-190, 2010. ,
DOI : 10.1016/S0093-7754(01)90072-7
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer, Breast Cancer Research, vol.15, issue.1, p.68, 2010. ,
DOI : 10.1038/nm0809-842
HER-2 and Topoisomerase II As Predictors of Response to Chemotherapy, Journal of Clinical Oncology, vol.26, issue.5, pp.736-744, 2008. ,
DOI : 10.1200/JCO.2007.15.4716
Chromatin retention of DNA damage sensors DDB2 and XPC through loss of p97 segregase causes genotoxicity, Nature Communications, vol.252, 2014. ,
DOI : 10.1073/pnas.0511160103
Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer, Journal of Mammary Gland Biology and Neoplasia, vol.99, issue.11, pp.201-212, 2010. ,
DOI : 10.1148/129.2.299
True XP group E patients have a defective UV-damaged DNA binding protein complex and mutations in DDB2 which reveal the functional domains of its p48 product, Human Molecular Genetics, vol.12, issue.13, pp.1507-1522, 2003. ,
DOI : 10.1093/hmg/ddg174
TNF-Induced Signaling in Apoptosis, Journal of Clinical Immunology, vol.19, issue.6, pp.350-364, 1999. ,
DOI : 10.1023/A:1020546615229
Recognition and repair of the cyclobutane thymine dimer, a major cause of skin cancers, by the human excision nuclease, Genes & Development, vol.17, issue.20, pp.2539-2551, 2003. ,
DOI : 10.1101/gad.1131003
Oxidative stress, inflammation, and cancer: How are they linked?, Free Radical Biology and Medicine, vol.49, issue.11, pp.1603-1616, 2010. ,
DOI : 10.1016/j.freeradbiomed.2010.09.006
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990475
Antiestrogens, Aromatase Inhibitors, and Apoptosis in Breast Cancer, Vitam. Horm, vol.71, pp.201-237, 2005. ,
DOI : 10.1016/S0083-6729(05)71007-4
ADP-ribose) polymerase-1 in the removal of UV-induced DNA lesions by nucleotide excision repair, Proc. Natl. Acad. Sci. U.S.A, vol.110, pp.1658-1663 ,
DDB2, an Essential Mediator of Premature Senescence, Molecular and Cellular Biology, vol.30, issue.11, pp.2681-2692, 2010. ,
DOI : 10.1128/MCB.01480-09
Damaged DNA Binding Protein 2 in Reactive Oxygen Species (ROS) Regulation and Premature Senescence, International Journal of Molecular Sciences, vol.37, issue.12, pp.11012-11026, 2012. ,
DOI : 10.3892/ijo_00000702
DDB2 Suppresses Epithelial-to-Mesenchymal Transition in Colon Cancer, Cancer Research, vol.73, issue.12, pp.3771-3782, 2013. ,
DOI : 10.1158/0008-5472.CAN-12-4069
The EORTC 10041/BIG 03-04 MINDACT trial is feasible: Results of the pilot phase, European Journal of Cancer, vol.47, issue.18, pp.2742-2749, 2011. ,
DOI : 10.1016/j.ejca.2011.09.016
ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1, Oncogene, vol.6, issue.24, pp.3490-3500, 2010. ,
DOI : 10.1016/S0092-8674(00)80625-X
Expression of p95HER2, a Truncated Form of the HER2 Receptor, and Response to Anti-HER2 Therapies in Breast Cancer, JNCI Journal of the National Cancer Institute, vol.99, issue.8, pp.628-638, 2007. ,
DOI : 10.1093/jnci/djk134
Structural Basis of UV DNA-Damage Recognition by the DDB1???DDB2 Complex, Cell, vol.135, issue.7, pp.1213-1223, 2008. ,
DOI : 10.1016/j.cell.2008.10.045
Mutation analysis and mRNA expression of trail-receptors in human breast cancer, International Journal of Cancer, vol.181, issue.20, pp.117-128, 2002. ,
DOI : 10.1002/ijc.10694
Adenovirus-mediated gene transduction of IkappaB or IkappaB plus Bax gene drastically enhances tumor necrosis factor (TNF)-induced apoptosis in human gliomas, 2000. ,
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer, Oncogene, vol.104, issue.34, pp.4741-4751, 2010. ,
DOI : 10.1016/S0002-9440(10)65297-2
Repeated observation of breast tumor subtypes in independent gene expression data sets, Proceedings of the National Academy of Sciences, vol.360, issue.9338, pp.8418-8423, 2003. ,
DOI : 10.1016/S0140-6736(02)11087-7
Estrogen Promotes Breast Cancer Cell Survival in an Inhibitor of Apoptosis (IAP)-dependent Manner, Hormones and Cancer, vol.46, issue.1, pp.127-135, 2010. ,
DOI : 10.1007/s12672-010-0018-6
WD40 proteins propel cellular networks, Trends in Biochemical Sciences, vol.35, issue.10, pp.565-574, 2010. ,
DOI : 10.1016/j.tibs.2010.04.003
DDB2 decides cell fate following DNA damage, Proceedings of the National Academy of Sciences, vol.24, issue.7, pp.10690-10695, 2009. ,
DOI : 10.1128/MCB.24.7.2649-2661.2004
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705559
Mechanism of O???2 generation in reduction and oxidation cycle of ubiquinones in a model of mitochondrial electron transport systems, Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol.936, issue.3, pp.377-385, 1988. ,
DOI : 10.1016/0005-2728(88)90014-X
Damaged DNA-binding protein 2 (DDB2) protects against UV irradiation in human cells and Drosophila, Journal of Biomedical Science, vol.17, issue.1, p.27, 2010. ,
DOI : 10.1186/1423-0127-17-27
URL : http://doi.org/10.1186/1423-0127-17-27
Overexpression of manganese superoxide dismutase promotes survival in cell lines after doxorubicin treatment, British Journal of Haematology, vol.54, issue.3, pp.457-463, 2003. ,
DOI : 10.1016/0092-8674(89)90944-6
Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM, Oncogene, vol.24, issue.8, pp.1348-1358, 2005. ,
DOI : 10.1038/sj.onc.1208300
Antitumor efficacy of sequential treatment with docetaxel and 5-fluorouracil against human oral cancer cells, International Journal of Oncology, 2012. ,
DOI : 10.3892/ijo.2012.1544
p53 Binds and Activates the Xeroderma Pigmentosum DDB2 Gene in Humans but Not Mice, Molecular and Cellular Biology, vol.22, issue.10, pp.3247-3254, 2002. ,
DOI : 10.1128/MCB.22.10.3247-3254.2002
Xeroderma pigmentosum complementation group E and UV-damaged DNA-binding protein, DNA Repair, vol.1, issue.8, pp.601-616, 2002. ,
DOI : 10.1016/S1568-7864(02)00052-6
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894533/pdf
Inhibition of the Canonical IKK/NFκB Pathway Sensitizes Human Cancer Cells to Doxorubicin, Cell Cycle, vol.6, issue.18, pp.2284-2292, 2007. ,
DOI : 10.4161/cc.6.18.4721
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?, Nature Reviews Drug Discovery, vol.104, issue.7, pp.579-591, 2009. ,
DOI : 10.4161/cbt.7.12.7067
Gene expression profiling predicts clinical outcome of breast cancer, Nature, vol.415, issue.6871, pp.530-536, 2002. ,
DOI : 10.1038/415530a
NF-??B2/p100 induces Bcl-2 expression, Leukemia, vol.17, issue.7, pp.1349-1356, 2003. ,
DOI : 10.1038/sj.leu.2402982
Histone H3 and H4 Ubiquitylation by the CUL4-DDB-ROC1 Ubiquitin Ligase Facilitates Cellular Response to DNA Damage, Molecular Cell, vol.22, issue.3, pp.383-394, 2006. ,
DOI : 10.1016/j.molcel.2006.03.035
Rationales for expression and altered expression of apoptotic protease activating factor-1 gene in gastric cancer, World Journal of Gastroenterology, vol.13, issue.38, pp.5060-5064, 2007. ,
DOI : 10.3748/wjg.v13.i38.5060
Mechanistic and Predictive Profiling of 5-Fluorouracil Resistance in Human Cancer Cells, Cancer Research, vol.64, issue.22, pp.8167-8176, 2004. ,
DOI : 10.1158/0008-5472.CAN-04-0970
The Role of Snail in EMT and Tumorigenesis, Current Cancer Drug Targets, vol.13, issue.9, pp.963-972, 2013. ,
DOI : 10.2174/15680096113136660102
On the Origin of Cancer Cells, Science, vol.123, issue.3191, pp.309-314, 1956. ,
DOI : 10.1126/science.123.3191.309
Inhibitor of apoptosis proteins and apoptosis, Acta Biochimica et Biophysica Sinica, vol.40, issue.4, pp.278-288, 2008. ,
DOI : 10.1111/j.1745-7270.2008.00407.x
Refinement of breast cancer classification by molecular characterization of histological special types, The Journal of Pathology, vol.9, issue.2, pp.141-150, 2008. ,
DOI : 10.1016/S0140-6736(05)17947-1
Taxanes and anthracyclines in early breast cancer: which first? The Lancet Oncology, pp.219-220, 2010. ,
Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73, Breast Cancer Research and Treatment, vol.591, issue.1???3, pp.301-313, 2011. ,
DOI : 10.1016/j.ejphar.2008.06.028
Resistance of Human Ovarian Cancer Cells to Tumor Necrosis Factor ?? Is a Consequence of Nuclear Factor ??B-Mediated Induction of Fas-Associated Death Domain-Like Interleukin-1??-Converting Enzyme-Like Inhibitory Protein, Endocrinology, vol.144, issue.2, pp.623-630, 2003. ,
DOI : 10.1210/en.2001-211024
The p38 Mitogen-activated Protein Kinase Augments Nucleotide Excision Repair by Mediating DDB2 Degradation and Chromatin Relaxation, Journal of Biological Chemistry, vol.46, issue.47, pp.32553-32561, 2008. ,
DOI : 10.1073/pnas.96.2.424
DNA Damage-Binding Complex Recruits HDAC1 to Repress Bcl-2 Transcription in Human Ovarian Cancer Cells, DNA Damage-Binding Complex Recruits HDAC1 to Repress Bcl-2 Transcription in Human Ovarian Cancer Cells, pp.370-380, 2014. ,
DOI : 10.1158/1541-7786.MCR-13-0281
Role of Nuclear Factor-??B in Breast and Colorectal Cancer, Current Allergy and Asthma Reports, vol.42, issue.17, pp.44-49, 2013. ,
DOI : 10.1080/00365520600880856
Travaux dirigés par le Prof, Licence en Sciences du Vivant et de la Santé, 2005. ,
Rôle de la protéine DDB2 dans la réponse des cellules tumorales mammaires aux agents thérapeutiques. Direction scientifique : Prof. Philippe Bécuwe et Dr, Stéphanie Grandemange, vol.2, 2010. ,
Influence de la protéine DDB2 sur la réponse des cellules tumorales mammaires aux agents anticancéreux Direction scientifique : Prof. Philippe Bécuwe et Dr Stéphanie Grandemange Master 1 ère année. Titre du projet : Expression et importance de la sémaphorine 6B, 2009. ,
Manganese superoxide dismutase in breast cancer: From molecular mechanisms of gene regulation to biological and clinical significance, Free Radical Biology and Medicine, vol.77, 2014. ,
DOI : 10.1016/j.freeradbiomed.2014.08.026
URL : https://hal.archives-ouvertes.fr/hal-01094585
Joint analysis of flow cytometry data and fluorescence spectra as a non-negative array factorization problem, Chemometrics and Intelligent Laboratory Systems, vol.137, pp.21-32, 2014. ,
DOI : 10.1016/j.chemolab.2014.06.003
URL : https://hal.archives-ouvertes.fr/hal-00990043
DDB2: A Novel Regulator of NF-??B and Breast Tumor Invasion, Cancer Research, vol.73, issue.16, pp.5040-52, 2013. ,
DOI : 10.1158/0008-5472.CAN-12-3655
Grandemange, S. DDB2 enhances the sensitivity of human breast cancer to chemotherapy by regulating its target genes expression Ecriture en cours ,
DDB2: a new regulator of metabolism in breast cancer cells ,
La protéine DDB2: un nouveau régulateur de la chimiosensibilité dans les cancers du sein, Journée Recherche « Cancérologie en Lorraine ,
DDB2 a new regulator of mitochondrial metabolism and sensitivity to cell death in human breast tumor cells, pp.27-28, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00747857
DDB2: a new regulator of metabolism and cell death in human breast cancer cells. CTRC-AACR San Antonio Breast Cancer Symposium Poster selected and abstract published in Cancer, p.24, 2012. ,
DDB2 a new regulator of metabolism and cell death in human breast tumor cells, Journée Biomédicale, vol.2, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00747606
DDB2 a new regulator of mitochondrial metabolism and sensitivity to cell death in human breast tumor cells, ONCOTRANS Congress, vol.8, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00747857